SMITH & NEPHEW PLC
25 May 2021
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.
On 23 May 2021, the following awards of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") vested under the Smith & Nephew Global Share Plan 2010.
PARTIAL VESTING ON 23 MAY 2021 OF CONDITIONAL SHARE AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2010:
The awards were granted under the Global Share Plan 2010 on 23 May 2019. One third of the shares vested on 23 May 2020, a further third vested on 23 May 2021 and the final third will vest on 23 May 2022. A number of Shares were sold to cover taxation obligations arising on the vesting of the awards.
The following relates to all individuals included in this notification:
| Reason for the notification | |
| Initial notification /Amendment | Initial notification |
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| Name | Smith & Nephew plc |
| LEI | 213800ZTMDN8S67S1H61 |
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| Description of the financial instrument, type of instrument
| Smith & Nephew plc ordinary shares of USD 0.20 each
|
| Identification code | ISIN: GB0009223206 |
| Nature of the transaction | Partial vesting of a Conditional Share Award granted on 23 May 2019 under the Smith & Nephew Global Share Plan 2010. |
| Date of Transaction | 2021 - 05 - 24 |
| Place of Transaction | London Stock Exchange (XLON) |
| Name | Director / PDMR | Price (£) | Volume | Aggregated information | Total Ordinary Share Holding following the transaction * | Total Ordinary Share Holding as a % of the Company's ISC following the transaction * |
| Myra Eskes (President APAC Region) | PDMR | 15.6325
| 8,566 (of which 0 were sold and 8,566 retained) | N/A Single Transaction | 26,898.32816 ordinary shares | 0.00304%
|
| Simon Fraser (President Advanced Wound Management) | PDMR | 15.6325
| 2,599 (of which 636 were sold and 1,963 retained) | N/A Single Transaction | 10,578.56333 ordinary shares | 0.00120%
|
* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.
Vickie Reuben
Deputy Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477410
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
